Background and Purpose-Brain microbleeds (MBs) are considered to be associated with cognitive decline and can be pathologically and topographically classified as cerebral amyloid angiopathy-related (located in lobar regions) and hypertensive microangiopathy-related (located in deep regions). We examined whether different effects on global cognitive function might be seen with different distributions of MBs. Methods-A total of 1279 adults without neurological disorders were studied prospectively. Subjects were divided into 4 groups: without-MBs group; lobar group; deep group; and with in both areas (diffuse group). The Mini-Mental State Examination was administered to determine global cognitive functions, with scores Ͻ27 regarded as subnormal. Results-MBs were detected in 98 subjects (8%): 36 subjects (3%) classified as lobar group, 48 subjects (4%) as deep group, and 14 subjects (1%) as diffuse group. Subnormal scores were found in 76 subjects (5.9%), associated with age, education, hypertension, severe white matter hyperintensities, and distribution and number of MBs. In the final model of logistic regression analysis, the deep group (OR, 2.79; 95% CI, 1.14 -6.79) was associated with subnormal scores, whereas the lobar group (OR, 0.77; 95% CI, 0.17-3.44) was not. Trend for the diffuse group did not reach the level of significance (OR, 5.01; 95% CI,). These trends were also seen in analysis using another cut-off point for subnormal score. Scores for total Mini-Mental State Examination and attention and calculation were significantly lower in the deep group and the diffuse groups compared with the without-MBs group.
refused to enroll, 1 individual could not undergo MRI because of severe claustrophobia, and 12 individuals had a history of neurological disorder or brain injury with abnormalities seen on MRI. Among the remaining 1357 subjects, 7 subjects displaying motion artifacts on MRI, 1 subject showing numerous cavernous angiomas, and 47 subjects with incomplete data for analysis were excluded. Finally, 23 subjects with serum triglyceride levels Ն400 mg/100 mL were also excluded, because low-density lipoprotein cholesterol cannot be accurately estimated from the formula. 14 As a result, we were able to prospectively study 1279 subjects (596 men; median age, 59.04 years; range, 27-85 years).
Baseline Assessment
We recorded age, sex, duration of education, family history of stroke, smoking status, blood pressure (BP), presence of hypertension and diabetes mellitus, and levels of total fasting serum total cholesterol, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol as clinical characteristics. Hypertension was defined as systolic BP (SBP) Ͼ140 mm Hg and/or diastolic BP Ͼ90 mm Hg, or use of antihypertensive medication. Diabetes mellitus was defined as fasting serum glucose level Ն126 mg/dL, hemoglobin A1c levels Ն6.5%, or use of antidiabetic medication. Patients who were smokers at the time of analysis were classified as current smokers. Family history of stroke and duration of education were obtained from each subject.
All subjects were examined by both a general physician and a certified neurosurgeon. Global cognitive function was assessed using the Mini-Mental State Examination (MMSE) 15 by a skilled nurse. In the primary analysis, total scores Ͻ27 were defined as subnormal in accordance with the latest MMSE guideline. 16 In an additional analysis, total scores Ͼ1.5 SD below the age-related mean were judged as subnormal. 9 
Magnetic Resonance Imaging
MRI was performed using a 1.5-T scanner (EXCELART Vantage, version 7.0; Toshiba Medical Systems). Gradient-echo T2*-weighted MRI, axial T1-weighted imaging, fluid-attenuated inversion recovery imaging, and fast spin-echo T2-weighted imaging were performed using the same section thickness, matrix, and parameters as described elsewhere. 9 MBs were defined on gradient-echo MRI as rounded areas of signal loss, Յ10 mm in diameter. Two investigators who were blinded to subject data reviewed the number and location of MBs. Symmetrical hypointensities in the globus pallidum caused by calcification and flow void artifacts of pial vessels were carefully excluded. Subject with MBs were divided into 3 groups by the location of MBs, 12 as follows. The lobar group showed strictly lobar MBs located in the cerebral cortices, subcortical white matter, or periventricular white matter. The deep group had strictly deep MBs located in the basal ganglia (BG); thalamus; white matter of the corpus callosum; internal, external, or extreme capsule; or infratentorially (brain stem or cerebellum). The diffuse group displayed diffuse MBs located in both lobar and deep regions. 17 White matter hyperintensities (WMH), periventricular hyperintensities, and lacunae were independently reviewed by 2 of the authors, who were blinded to subject data, and were rated as described elsewhere. 9, 18 Values of interrater reliability for MRI findings, expressed as Cohen's kappa, were as follows: presence of MBs, 0.73; of lacunae, 0.57; of severe WMH, 0.58; and of severe periventricular hyperintensities, 0.47. Each value of intrarater reliability for MRI findings was determined from 50 randomly selected scans that were scored twice, again expressed as Cohen's kappa. Each value was within the range of 0.65 to 0.86.
Using a computer-assisted processing system (Image J, version 1.38; National Institutes of Health) according to previous studies, 9, 19 we calculated percentage brain value (% brain) as an index of cerebral atrophy.
Statistics
Statistical analysis was performed using the Statistical Analysis System version 9.1 (SAS Institute). We preliminarily examined the relevance of the variables affecting MB distribution. In the primary tests, associations between MB distributions and subnormal MMSE score were investigated. Analyses were performed with the 2 groups (without-MBs versus with any-MBs) and the 4 groups (without-MBs group, lobar group, deep group, and diffuse group). To compare variables among groups, univariate analyses with the 2 test, Mann-Whitney U test, Kruskal-Wallis test, and 1-way analysis of variance using a Dunnett q or C test were performed, as appropriate. Variables with PϽ0.20 on univariate analysis, in addition to age and sex, were entered into multiple logistic regression analyses. Values of PϽ0.05 were considered statistically significant.
Results
MBs were detected in 98 subjects (7.7% (Table S1 ).
For the total subjects, mean MMSE score was 29.50 (range, 20 -30) . Scores Ͻ27 were found in 76 subjects (5.9%; score 26, nϭ40; 25, nϭ17; 24, nϭ8; 23, nϭ9; 22, nϭ1; and 20, nϭ1).
As for the results of the preliminary tests, differences in clinical characteristics and MRI findings among the groups for MBs distribution are shown in S2. In the comparison between without-MBs and any-MBs group, there were differences in age, BPs, % brain, and prevalences of hypertension, diabetes mellitus, lacunae, and severe WMH and periventricular hyperintensities. In the comparison among 4 groups, there were additional differences in sex, high-density lipoprotein cholesterol, and prevalences of current smoker and family history of stroke. The number of MBs was significantly higher in the diffuse group than in the lobar group or the deep group. No difference in number of MBs was apparent between the lobar group and the deep group. In the diffuse group, median (interquartile range) numbers of MBs were 1.5 (1.0 -5.0) in the lobar regions and 1.5 (1.0 -2.0) in the deep regions (data were not shown). The results of logistic regression analyses for factors associated with each distributional pattern of MBs are shown in Table S3 . SBP, lacunae, and severe WMH had relevance to subjects with any-MBs, as well as the deep group, and were more pronounced for the diffuse group. Even if hypertension or BP were entered into the logistic regression analysis instead of SBP, similar results were obtained (data not shown).
As for the results of the primary tests, differences in variables between normal and subnormal MMSE score (Ͻ 27) groups are shown in Table 1 . Subnormal scores were associated with age; duration of education; hypertension; SBP; presence, number, and distribution of MBs; and severe WMH. To assess the primary hypothesis, logistic regression analyses were performed ( Table 2) . As a strong correlation existed between hypertension and SBP (Spearman correlation coefficient (ñ), 0.66) and SBP displayed a lower probability value than did hypertension, SBP was used for multivariate analysis. Models were adjusted for age, sex, and clinical variables (Model 1); then for the variables entered into Model 1, and severe WMH (Model 2); and then for variables entered into Model 2, and number of MBs (Model 3). Results from Models 1 and 2 showed that, compared with the without-MBs MRI indicates magnetic resonance imaging; IQR, interquartile range; SBP, systolic blood pressure; DBP, diastolic blood pressure; T-cho, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; MR, magnetic resonance; MB, microbleed; WMH, white matter hyperintensities; PVH, periventricular hyperintensities.
Continuous variables were compared using the Mann-Whitney U test, and are presented as medians with IQRs. Mean with SD is also presented in number of lacunae and MBs. The Chi-square test was used for frequency comparisons.
group, presence of any-MBs was significantly associated with subnormal score. These associations were more pronounced for the deep group and the diffuse group, but were not seen in the lobar group. In Model 3, the deep group still displayed significant associations with subnormal score. In that model, similar trends were also seen in the any-MBs and diffuse groups, but did not reach the level of statistical significance. Even if the presence of lacunae, which has been considered to be associated with cognitive decline (but did not show relevance to subnormal scores on univariate analysis in the present study), was additionally entered into Models 2 and 3, no changes in these trends were identified (Table S4) . The additional analysis, in which MMSE scores Ͼ1.5 SD below the mean for each given age were defined as subnormal (nϭ93, 7.3%), demonstrated the same trends (Table S5-6) . Table 3 compares MMSE total and subscores among groups. In comparison between the 2 groups, scores for total MMSE and attention and calculation were significantly lower with any-MBs. Among the 4 groups, such scores were significantly lower with the deep group and the diffuse groups compared with the without-MBs group, and lowest in the diffuse group. All scores were similar between the lobar and without-MBs groups.
Discussion
Recent cross-sectional studies investigated the association between MB location and cognitive dysfunction. 10, 11 However, these studies included subjects with dementia disorders 10 and previous stroke, 11 thus including the possibility of substantial bias in terms of coexisting pathogeneses for these diseases. The present study investigated the distributional impact of MBs on global cognitive function in adults without neurological disorder. All subjects were living independently without neurological disorder and displayed normal results on neurological examination. The result of significant differences in the impact of MBs on global cognitive function according to the distributional pattern is consistent with our hypothesis. That is, the effect of deep MBs on global cognitive function appears independently of neurological disorder and coexisting risk factors for stroke or dementia.
The significant associations in this study between deep MBs and cerebrovascular risk factors are inconsistent with previous studies, 12, 13, 17 and suggest that deep MBs might be closely attributable to hypertensive microangiopathy. Conversely, no risk factors other than severe periventricular hyperintensities were associated with lobar MBs, which are considered a consequence of underlying CAA. 20, 21 Such reduced relevance of lobar MBs to cerebrovascular risk factors is in line with previous studies. 12, 13, 17 Thus, our main result that subnormal MMSE scores are significantly correlated with deep MBs, but not with lobar MBs, suggests that MB-related global cognitive dysfunction seems to occur based on hypertensive pathogenesis, rather than CAA; this implies that control of hypertension can reduce MB-related cognitive dysfunction. A close pathological relationship between lobar MBs and CAA, where deposition of A␤-protein in the vascular media and adventitia leads to loss of integrity of the vessel wall with resulting brain hemorrhage, 22 has been demonstrated with assessments of ApoE genotype in the general population, 12, 13 as well as with pathology in brains with Alzheimer's disease. 23 CAA contributes to cognitive decline in Alzheimer's disease, 24 but lobar MBs showed no relevance to global cognitive dysfunction in our analyses with most middle-aged adults. Such discrepancies might be explained largely by the hypothesis that abnormal processing of A␤-protein may be 1 of the initiating events in the development of Alzheimer's disease, including neuronal dysfunction and neurodegeneration, becoming key pathological processes later in the disease process. 25, 26 Diffuse MBs, which were more frequently seen in older persons in this study, had more pronounced relevance to cerebrovascular risk factors, indicating that diffuse MBs might represent chronic extension of deep MBs with or without CAA. 17 The associations between diffuse MBs and global cognitive dysfunction seem to be pronounced, but did not reach the significant level in final model additionally adjusted for number of MBs; this implies that the effect of diffuse MBs on cognition might result partially from increased number of MBs with a more severe hypertensive pathogenesis. However, diffuse MBs could have a mixed pathogenesis involving vascular risk factors and CAA. 1 Therefore, the tendency to have severe cognitive decline in the diffuse group might serve as an additional argument for the notion that both hypertensive microangiopathy and CAA resulting from amyloid cascade act synergistically to cause dementia. 26 The mechanisms underlying pathological associations between hypertensive MBs and global cognitive dysfunction, particularly attention and calculation, remain unclear. In previous studies, 8, 9 as well as in the current study, that deep MBs are frequently located in the BG may offer some hints to explaining such associations. Cognitive dysfunction is also common in subjects with BG disease, as represented by Parkinson's disease. Cognitive deficits in the early stages of Parkinson's disease are characterized by executive dysfunction, including impairments in attention 27 and calculation, 28 reflecting involvement of the BG and frontal-subcortical circuits. The predominance of deep MBs in the BG may thus cause cognitive dysfunction resulting from primary or secondary damage to cholinergic pathways in the frontalsubcortical circuits.
Several limitations must be considered in the interpretation of this study. First, selection bias might have been present. Given that our subjects were adults who sought health screening tests of the brain at their own expense, a selection bias may have existed toward individuals who were relatively affluent or had a high degree of concern regarding their own health, and might have been affected by differences in educational background and socioeconomic status, which are considered risk factors for cardiovascular disease. 29 Second, we used the MMSE as the sole method to assess cognitive function. This measure reportedly offers relatively low sensitivity for the assessment of cognitive function in patients with cerebral small vessel disease. 30 However, the MMSE is used worldwide as a cognitive assessment tool, and the relatively large sample in this study would reduce the impact of bias. Third, this study included only a relatively small sample of individuals age Ն70 years old (7.8%), although this age group would have been expected to show the greatest prevalence of CAA-related MBs. The present analyses with mostly middle-aged adults might thus remain insufficient to conclude whether lobar MBs are associated with cognitive decline among individuals without neurological disorders. Finally, the ethnic background of the study population should be considered. Because Asian populations display more prominent cerebrovascular pathology compared with nonAsian populations, additional investigation may be needed to clarify whether our findings are more generally applicable.
Some discussion is warranted regarding the late-breaking results from the Rotterdam Scan Study, 31 which have indicated that presence of numerous MBs, particularly in a strictly lobar location, was associated with cognitive decline in a general population. Some methodological differences exist between that study and our own, such as the parameters of gradient-echo MRI, statistical procedures, and the abovementioned limitations. Of those, differences in ethnic background (Asian versus non-Asian) might be a central contributor to the contradictory findings. In fact, among the subjects with MBs in these studies, the proportions of subjects in the (strict) lobar group and the other (deep group and diffuse group, as so-called subjects with deep or infratentorial MBs in the Rotterdam Scan Study) were completely reversed, at 68% and 32% in the Rotterdam Scan Study, and 37% and 63% in this study, respectively. The dominance of distributional patterns for MBs according to the ethnic backgrounds of each study sample might thus have influenced the cognitive results.
Conclusions
In conclusion, this study offers evidence that the impacts of MBs on global cognitive function differ according to the topographical distribution in adults without neurological disorder, indicating that, in the Japanese population, MB-related global cognitive dysfunction seems to occur based on hypertensive pathogenesis, rather than based on CAA. 
